Lauri Lehtimäki

5.4k total citations · 1 hit paper
156 papers, 2.5k citations indexed

About

Lauri Lehtimäki is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Lauri Lehtimäki has authored 156 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Pulmonary and Respiratory Medicine, 95 papers in Physiology and 16 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Lauri Lehtimäki's work include Asthma and respiratory diseases (92 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (64 papers) and Respiratory and Cough-Related Research (48 papers). Lauri Lehtimäki is often cited by papers focused on Asthma and respiratory diseases (92 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (64 papers) and Respiratory and Cough-Related Research (48 papers). Lauri Lehtimäki collaborates with scholars based in Finland, Sweden and Norway. Lauri Lehtimäki's co-authors include Hannu Kankaanranta, Eeva Moilanen, Celeste Porsbjerg, Dominick Shaw, Väinö Turjanmaa, Erik Melén, Pinja Ilmarinen, Seppo Saarelainen, Leena E. Tuomisto and Sami Saarelainen and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lauri Lehtimäki

142 papers receiving 2.5k citations

Hit Papers

align trajectories

Peers

Lauri Lehtimäki

PHYSI

PRM

IA

IMMUN

MB

Nicola Wilson United Kingdom

Silvia Carraro Italy

Yuji Tohda Japan

Paula Rytilä Finland

Kefang Lai China

Sharon Sullivan-Rubin Australia

Vera M. Keatings Ireland

Pinja Ilmarinen Finland

Don Cockcroft Canada

John D. Brannan Australia

Nicola Wilson United Kingdom

Lauri Lehtimäki

1.9k ×1.2

PHYSI

1.8k ×1.1

PRM

220 ×1.0

IA

167 ×0.8

IMMUN

113 ×0.6

MB

Citations per year, relative to Lauri Lehtimäki Lauri Lehtimäki (= 1×) peers Nicola Wilson

Countries citing papers authored by Lauri Lehtimäki

Since Specialization

Citations

This map shows the geographic impact of Lauri Lehtimäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauri Lehtimäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauri Lehtimäki more than expected).

Fields of papers citing papers by Lauri Lehtimäki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauri Lehtimäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauri Lehtimäki. The network helps show where Lauri Lehtimäki may publish in the future.

Co-authorship network of co-authors of Lauri Lehtimäki

This figure shows the co-authorship network connecting the top 25 collaborators of Lauri Lehtimäki. A scholar is included among the top collaborators of Lauri Lehtimäki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauri Lehtimäki. Lauri Lehtimäki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Toppila‐Salmi, Sanna, Annina Lyly, Johanna Simin, et al.. (2025). Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps. Clinical and Translational Allergy. 15(2). e70032–e70032. 1 indexed citations

2.

Lehtimäki, Lauri, Daniil Lisik, R.S. Jadhav, et al.. (2025). Reference Values and Determinants of Fractional Exhaled Nitric Oxide in a Representative Adult Population in Western Sweden. Clinical and Translational Allergy. 15(9). e70107–e70107. 1 indexed citations

3.

Woodcock, Ashley, Alex Wilkinson, Christer Janson, et al.. (2024). Thoughtful prescription of inhaled medication has the potential to reduce inhaler-related greenhouse gas emissions by 85%. BMJ Open Respiratory Research. 11(1). e001782–e001782. 4 indexed citations

4.

Karjalainen, Jussi, et al.. (2024). Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial. Respiratory Medicine. 230. 107693–107693. 2 indexed citations

5.

Le, Tham, David Price, Bill Cook, et al.. (2024). Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry. Journal of Asthma and Allergy. Volume 17. 1055–1069. 5 indexed citations

6.

Lehtimäki, Lauri, Linda Ekerljung, Helena Bäckman, et al.. (2024). Lifetime asthma incidence is related to age at onset and allergies in western Sweden. Clinical and Translational Allergy. 14(12). e70015–e70015. 5 indexed citations

7.

Buchheit, Kathleen M., Dominick Shaw, Geoffrey Chupp, et al.. (2024). Interleukin‐5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils. Allergy. 79(10). 2662–2679. 21 indexed citations

8.

Aakko, Juhani, et al.. (2023). Type 2 Low Biomarker Stability and Exacerbations in Severe Uncontrolled Asthma. Biomolecules. 13(7). 1118–1118. 7 indexed citations

9.

Karjalainen, Jussi, et al.. (2023). Age at asthma diagnosis and onset of symptoms among adults with allergic and non-allergic asthma. European Clinical Respiratory Journal. 10(1). 2269653–2269653. 2 indexed citations

10.

Järnstedt, Jorma, Jura Numminen, A Lehtinen, et al.. (2023). Ultra-low-dose CBCT: new cornerstone of paranasal sinus imaging. Rhinology Journal. 61(3). 221–230. 3 indexed citations

11.

Tuomisto, Leena E., Pinja Ilmarinen, Lauri Lehtimäki, et al.. (2021). Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults. ERJ Open Research. 7(4). 293–2021. 4 indexed citations

12.

Karjalainen, Jussi, et al.. (2021). Higher prevalence but later age at onset of asthma in cross‐country skiers compared with general population. Scandinavian Journal of Medicine and Science in Sports. 31(12). 2259–2266. 6 indexed citations

13.

Kankare, Elina, Jussi Karjalainen, Lauri Lehtimäki, et al.. (2021). Multiple Chemical Sensitivity in Patients Exposed to Moisture Damage at Work and in General Working-Age Population—The SAMDAW Study. International Journal of Environmental Research and Public Health. 18(23). 12296–12296. 3 indexed citations

14.

Tommola, Minna, Ha‐Kyeong Won, Pinja Ilmarinen, et al.. (2020). Relationship between age and bronchodilator response at diagnosis in adult-onset asthma. Respiratory Research. 21(1). 179–179. 3 indexed citations

15.

Vähätalo, Iida, Pinja Ilmarinen, Leena E. Tuomisto, et al.. (2020). 12-year adherence to inhaled corticosteroids in adult-onset asthma. ERJ Open Research. 6(1). 324–2019. 23 indexed citations

16.

Tommola, Minna, Pinja Ilmarinen, Leena E. Tuomisto, Lauri Lehtimäki, & Hannu Kankaanranta. (2019). Occupational exposures and asthma–COPD overlap in a clinical cohort of adult-onset asthma. ERJ Open Research. 5(4). 191–2019. 9 indexed citations

17.

Tuomisto, Leena E., Pinja Ilmarinen, Lauri Lehtimäki, Minna Tommola, & Hannu Kankaanranta. (2018). Immediate bronchodilator response in FEV₁as a diagnostic criterion for adult asthma. European Respiratory Journal. 53(2). 1800904–1800904. 20 indexed citations

18.

Ilmarinen, Pinja, Leena E. Tuomisto, Onni Niemelä, et al.. (2018). Daily physical activity and lung function decline in adult-onset asthma: a 12-year follow-up study. European Clinical Respiratory Journal. 5(1). 1533753–1533753. 30 indexed citations

19.

Lehtimäki, Lauri, Mari Hämäläinen, Katriina Vuolteenaho, et al.. (2014). Adipokines NUCB2/Nesfatin-1 and Visfatin as Novel Inflammatory Factors in Chronic Obstructive Pulmonary Disease. Mediators of Inflammation. 2014. 1–6. 37 indexed citations

20.

Lehtimäki, Lauri, Hannu Kankaanranta, Sami Saarelainen, et al.. (2009). Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD. European Respiratory Journal. 35(1). 72–78. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact